Diffuse Large B-Cell Lymphoma Serum
Diffuse Large B-Cell Lymphoma Serum - Human diffuse large B-cell lymphoma (DLBCL) serum samples collected from clinically confirmed donors. Ideal for metabolic and proteomic profiling.
Human Diffuse Large B-Cell Lymphoma Serum for Research
Our Diffuse Large B-Cell Lymphoma Serum is sourced from IRB-consented donors clinically diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL). Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for biomarker studies.
Product Features
- Collected from clinically confirmed DLBCL donors
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
De-identified Donor Data
- Diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported allergy and infectious disease history
Applications
- Biomarker discovery for DLBCL
- Metabolic and protein profiling
- Therapeutic candidate screening and validation
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Diffuse Large B-Cell Lymphoma serum is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Serum Isolation
Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Serum
Frequently Asked Questions
Ask a Question
Need a custom Serum cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.